It is to look at the full picture: triggers, inflammation, gut health, immune burden, nervous system stress, nutrient status, and the factors that may be making mast cells more unstable
Published evidence is narrower: topical skin and wound studies exist, hair claims are more indirect, and FDA materials caution that injectable GHK-Cu has limited human safety data [2], [3], [8]
Common approaches include: 12 weeks on, 4 weeks off 16 weeks on, 6-8 weeks off Use only during specific fat loss phases, then discontinue Cycling provides periodic breaks that may allow the body to normalize
People who experience significant nausea on GLP-1 receptor agonists may tolerate tirzepatide with B12 better than formulations without it
Figure 1: Changes in A) escape latency and B) time spent in quadrants across all treatment groups